Tetramethrin: Difference between revisions
CSV import |
No edit summary |
||
| Line 36: | Line 36: | ||
{{stub}} | {{stub}} | ||
== Tetramethrin == | == Tetramethrin == | ||
<gallery> | <gallery> | ||
Latest revision as of 01:07, 17 March 2025
Synovial Chondromatosis is a rare, benign (non-cancerous) condition that involves the synovium, which is the thin layer of tissue lining the joints and tendons. This condition is characterized by the formation of cartilaginous nodules (chondromas) in the synovium.
Symptoms[edit]
The symptoms of Synovial Chondromatosis can vary greatly from person to person. Some people may experience no symptoms at all, while others may have severe pain and swelling in the affected joint. Other common symptoms include:
- Joint pain
- Joint swelling
- Joint stiffness
- Decreased range of motion in the affected joint
- Joint effusion (fluid accumulation)
Causes[edit]
The exact cause of Synovial Chondromatosis is unknown. However, it is thought to occur when the synovium undergoes metaplasia, a process in which one type of cell transforms into another type. In this case, the synovial cells transform into chondrocytes, which are cells that produce cartilage.
Diagnosis[edit]
Diagnosis of Synovial Chondromatosis typically involves a combination of physical examination, medical history, and imaging tests such as X-ray, MRI, or CT scan. In some cases, a biopsy may be performed to confirm the diagnosis.
Treatment[edit]
Treatment for Synovial Chondromatosis typically involves surgery to remove the chondromas and the affected synovium. In some cases, Physical therapy may also be recommended to help improve joint function and reduce pain.
Prognosis[edit]
The prognosis for Synovial Chondromatosis is generally good, especially if the condition is detected and treated early. However, in some cases, the condition can recur after treatment.
See Also[edit]
References[edit]
<references />


